Zobrazeno 1 - 10
of 202
pro vyhledávání: '"Motoi Aoe"'
Publikováno v:
The Journal of the Japanese Association for Chest Surgery. 36:766-772
Publikováno v:
The Journal of the Japanese Association for Chest Surgery. 36:562-566
Publikováno v:
The Journal of the Japanese Association for Chest Surgery. 34:688-692
Publikováno v:
The Journal of the Japanese Association for Chest Surgery. 34:265-269
Autor:
Kenichi Okubo, Yuko Komase, Toshinori Hashizume, Motoi Aoe, Mitsutomo Kohno, Yoshinori Okada, Hirohisa Horinouchi, Yoshinobu Ohsaki, Fumihiro Asano
Publikováno v:
Journal of Bronchology & Interventional Pulmonology
Supplemental Digital Content is available in the text.
Background: The Japan Society for Respiratory Endoscopy performed a nationwide survey to evaluate the current status and complications of bronchoscopy. Data on deaths due to bronchoscopy, co
Background: The Japan Society for Respiratory Endoscopy performed a nationwide survey to evaluate the current status and complications of bronchoscopy. Data on deaths due to bronchoscopy, co
Publikováno v:
The Journal of the Japanese Association for Chest Surgery. 33:453-459
Publikováno v:
The Journal of the Japanese Association for Chest Surgery. 33:150-155
Publikováno v:
The Journal of the Japanese Association for Chest Surgery. 32:216-220
Autor:
Junichi Soh, Hiroshi Date, Junichi Sakamoto, Hiroshige Nakamura, Masao Nakata, Motoi Aoe, Shinichi Toyooka, Katsuyuki Hotta, Satoshi Morita, Norihito Okumura, Motohiro Yamashita
Publikováno v:
International journal of clinical oncology. 24(11)
Pathological stage (pStage) and histological subtype are strong determinants of the treatment strategy for non-small cell lung cancer (NSCLC). Setouchi Lung Cancer study Group (SLCG) recently reported the results of a multicenter trial (SLCG0401) ind
Autor:
Kazuhiko Kataoka, Hiroshige Nakamura, Keitaro Matsuo, Hiroshi Date, Norihito Okumura, Shinichi Toyooka, Masafumi Kataoka, Masao Nakata, Junichi Soh, Yoshifumi Sano, Minoru Fukuda, Shinsuke Kajiwara, Motoi Aoe, Katsuyuki Hotta
Publikováno v:
Japanese Journal of Clinical Oncology
The feasibility of the S-1 administration schedules (the 4-week versus the 2-week) showed no significant difference for adjuvant chemotherapy among pathological-Stage IA non–small-cell lung cancer patients.
Objective The aim of this multicente
Objective The aim of this multicente